Tramadol controlled release - Labopharm

Drug Profile

Tramadol controlled release - Labopharm

Alternative Names: Contramal Uno; Dolpar; Durotram XR; Monoalgic L.P.; Monotramal L.P.; Noax Uno; NS-24; Once-daily tramadol; Once-daily tramadol MP; Onetram; Ryzolt; Tradorec XL; TramaConti CR; Tramadol CR; Tramadol extended release; Tramadolor einmal täeglich; Tridural; Unitrama

Latest Information Update: 24 Apr 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Labopharm
  • Developer Altus Formulation Inc; Nippon Shinyaku
  • Class Antidepressants; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Opioid analgesics; Phenyl ethers; Small molecules
  • Mechanism of Action Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cancer pain; Pain

Most Recent Events

  • 08 Mar 2016 Biomarkers information updated
  • 26 Mar 2015 Registered for Cancer pain and Chronic pain in Japan (PO)
  • 16 Jun 2014 Preregistration for Cancer pain in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top